# A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

> **NCT02205320** · PHASE1 · UNKNOWN · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 192 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **BIOLOGICAL:** DRL_PG
- **BIOLOGICAL:** Pegfilgrastim Form A
- **BIOLOGICAL:** Pegfilgrastim Form B

## Key facts

- **NCT ID:** NCT02205320
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205320, "A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02205320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*